Over-Expressed miR-224 promotes the progression of cervical cancer via targeting RASSF8

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Huang, Yongjie ^a   Li, Yang ^a   Wang, Fen F ^a   Lv, Weiguo ^a   Xie, Xing ^a   Cheng, Xiaodong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 224; RAS ASSOCIATION DOMAIN FAMILY 8; RAS PROTEIN; UNCLASSIFIED DRUG; MIRN224 MICRORNA, HUMAN; RASSF8 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; TUMOR VOLUME; UPREGULATION; UTERINE CERVIX CANCER; DISEASE COURSE; GENETICS; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ADULT; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; MICRORNAS; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84990950090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162378     Document Type: Article

References (36)

1. Lea JS, Lin KY. Cervical Cancer. Obstetrics and Gynecology Clinics of NorthAmerica. 2012; 39(2):233-53. http://dx.doi.org/10.1016/j.ogc.2012.02.008. doi: 10.1016/j.ogc.2012.02.008 PMID: 22640713
2. FormanD, de MartelC, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012; 30 Suppl 5:F12-23. Epub 2012/12/05. doi: 10.1016/j.vaccine.2012.07.055 PMID: 23199955.
3. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al.Worldwide burden of cervical cancer in 2008. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2011; 22(12):2675-86. Epub 2011/04/08. doi: 10.1093/annonc/mdr015 PMID: 21471563.
4. Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, et al. Recommendations for cervical cancer prevention in Asia Pacific. Vaccine. 2008; 26 Suppl 12:M89-98. Epub 2008/11/01. doi: 10. 1016/j.vaccine.2008.06.020 PMID: 18945418.
5. Kanavos P. The rising burden of cancer in the developing world. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2006; 17 Suppl 8:viii15-viii23. doi: 10.1093/annonc/mdl983 PMID: 16801335.
6. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5):843-54. Epub 1993/12/03. PMID: 8252621.
7. Arasu P, Wightman B, Ruvkun G. Temporal regulation of lin-14 by the antagonistic action of two other heterochronic genes, lin-4 and lin-28. Genes & development. 1991; 5(10):1825-33. Epub 1991/10/01. PMID: 1916265.
8. Pillai RS, Bhattacharyya SN, FilipowiczW. Repression of protein synthesis by miRNAs: how many mechanisms' Trends in cell biology. 2007; 17(3):118-26. doi: 10.1016/j.tcb.2006.12.007 PMID: 17197185.
9. HartmannC, Corre-MenguyF, Boualem A, Jovanovic M, Lelandais-BriereC. [MicroRNAs: a new class of gene expression regulators]. Medecine sciences: M/S. 2004; 20(10):894-8. Epub 2004/10/06. doi: 10.1051/medsci/20042010894 PMID: 15461967.
10. Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Current genomics. 2010; 11(7):537-61. Epub 2011/05/03. doi: 10.2174/138920210793175895 PMID: 21532838; PubMed Central PMCID: PMCPMC3048316.
11. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006; 25(46):6188-96. doi: 10.1038/sj.onc.1209913 PMID: 17028598.
12. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. The Journal of Pathology. 2011; 224(4):484-95. doi: 10.1002/path.2873 PMID: 21503900
13. An F, Olaru AV, Mezey E, Xie Q, Li L, Piontek KB, et al. MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer. Journal of clinical medicine. 2015; 4(9):1713-28. Epub 2015/09/08. doi: 10. 3390/jcm4091713 PMID: 26343737.
14. Wang Y, Toh HC, Chow P, Chung AY, Meyers DJ, Cole PA, et al. MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2012; 26(7):3032-41. doi: 10.1096/fj.11-201855 PMID: 22459148; PubMed Central PMCID: PMC3382089.
15. Ma D, Tao X, Gao F, Fan C, Wu D. miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncology letters. 2012; 4(3):483-8.Epub 2013/06/07. doi: 10.3892/ol.2012.742 PMID: 23741247; PubMed Central PMCID:PMCPMC3673647.
16. Wang Y, Lee AT, Ma JZ,Wang J, Ren J, Yang Y, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. The Journal of biological chemistry. 2008; 283(19):13205-15. doi: 10.1074/jbc.M707629200 PMID: 18319255.
17. Huang L, Dai T, Lin X, Zhao X, Chen X,Wang C, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochemical and biophysical research communications. 2012; 425(2):127-33. doi: 10.1016/j.bbrc.2012.07.025 PMID: 22809510.
18. Cui R, Kim T, Fassan M, MengW, Sun HL, Jeon YJ, et al. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 2015; 6(26):21802-15. Epub 2015/08/27. PMID: 26307684.
19. Cui R, MengW, Sun HL, Kim T, Ye Z, Fassan M, et al. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112(31):E4288-97. Epub 2015/07/19. doi: 10.1073/pnas.1502068112 PMID: 26187928; PubMed Central PMCID:PMCPMC4534291.
20. Amankwatia EB, Chakravarty P, Carey FA, Weidlich S, Steele RJ, Munro AJ, et al. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and-independent mechanisms. British journal of cancer. 2015; 112(9):1480-90. Epub 2015/04/29. doi: 10.1038/bjc.2015.125 PMID: 25919696; PubMed Central PMCID: PMCPMC4453675.
21. Shen SN,Wang LF, Jia YF, Hao YQ, Zhang L,Wang H. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagnostic pathology. 2013; 8:69. Epub 2013/05/02. doi: 10.1186/1746-1596-8-69 PMID: 23631806; PubMed Central PMCID: PMCPMC3661379.
22. MendesND, Freitas AT, Sagot MF. Current tools for the identification of miRNA genes and their targets. Nucleic acids research. 2009; 37(8):2419-33. Epub 2009/03/20. doi: 10.1093/nar/gkp145 PMID: 19295136; PubMed Central PMCID:PMCPMC2677885.
23. Sherwood V, Recino A, Jeffries A,Ward A, Chalmers AD. The N-terminal RASSF family: a new group of Ras-Association-domain-containing proteins, with emerging links to cancer formation. The Biochemical journal. 2010; 425(2):303-11. Epub 2009/12/23. doi: 10.1042/bj20091318 PMID: 20025613.
24. Underhill-Day N, Hill V, Latif F. N-terminalRASSF family: RASSF7-RASSF10. Epigenetics. 2011; 6 (3):284-92. doi: 10.4161/epi.6.3.14108 PMID: 21116130
25. van derWeyden L, Adams DJ. The Ras-Association domain family (RASSF) members and their role in human tumourigenesis. Biochimica et biophysica acta. 2007; 1776(1):58-85. Epub 2007/08/19. doi: 10.1016/j.bbcan.2007.06.003 PMID: 17692468; PubMed Central PMCID:PMCPMC2586335.
26. Lock FE, Underhill-Day N, Dunwell T, MatallanasD, CooperW, Hesson L, et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene. 2010; 29(30):4307-16. Epub 2010/06/02. doi: 10.1038/onc.2010.192 PMID: 20514026.
27. Avruch J, Xavier R, Bardeesy N, Zhang XF, Praskova M, Zhou D, et al. Rassf family of tumor suppressor polypeptides. The Journal of biological chemistry. 2009; 284(17):11001-5. Epub 2008/12/19. doi: 10.1074/jbc.R800073200 PMID: 19091744; PubMed Central PMCID:PMCPMC2670104.
28. Lai EC. Predicting and validating microRNA targets. Genome biology. 2004; 5(9):115. Epub 2004/09/04 doi: 10.1186/gb-2004-5-9-115 PMID: 15345038; PubMed Central PMCID:PMCPMC522861.
29. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7):1401-14. Epub 2007/07/03. doi: 10.1016/j.cell.2007.04.040 PMID: 17604727; PubMed Central PMCID:PMCPMC2681231.
30. Dostie J, Mourelatos Z, Yang M, SharmaA, Dreyfuss G. Numerous microRNPs in neuronal cells containing novel microRNAs. RNA (New York, NY). 2003; 9(2):180-6.Epub 2003/01/30. PMID: 12554860; PubMed Central PMCID:PMCPMC1370383.
31. LuiWO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer research. 2007; 67(13):6031-43. doi: 10.1158/0008-5472.CAN-06-0561 PMID: 17616659.
32. Mencia N, Selga E, Noe V, Ciudad CJ. Underexpression of miR-224 in methotrexate resistant human colon cancer cells. Biochemical pharmacology. 2011; 82(11):1572-82. doi: 10.1016/j.bcp.2011.08.009 PMID: 21864507.
33. Mavridis K, Stravodimos K, Scorilas A. Downregulation and prognostic performance of microRNA 224 expression in prostate cancer. Clinical chemistry. 2013; 59(1):261-9. doi: 10.1373/clinchem.2012. 191502 PMID: 23136246.
34. Falvella FS, Manenti G, Spinola M, PignatielloC, Conti B, Pastorino U, et al. Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene. 2006; 25(28):3934-8. Epub 2006/02/08. doi: 10.1038/sj.onc.1209422 PMID: 16462760.
35. Falvella FS, Spinola M, Manenti G, Conti B, Pastorino U, Skaug V, et al. Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk. Lung cancer (Amsterdam, Netherlands). 2007; 56(1):1-7. Epub 2006/12/30. PMID: 17194498.
36. Langton PF, Colombani J, Chan EH,Wepf A, Gstaiger M, Tapon N. The dASPP-dRASSF8 complex regulates cell-cell adhesion during Drosophila retinal morphogenesis. Current biology: CB. 2009; 19 (23):1969-78. Epub 2009/11/26. doi: 10.1016/j.cub.2009.10.027 PMID: 19931458.